geraniin has been researched along with Lung Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Pan, L; Wang, S; Yin, J | 1 |
| Ko, H | 1 |
2 other study(ies) available for geraniin and Lung Adenocarcinoma
| Article | Year |
|---|---|
Geraniin induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro and in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Glucosides; Humans; Hydrolyzable Tannins; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; S Phase | 2013 |
Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anoikis; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Glucosides; Humans; Hydrolyzable Tannins; Lung; Lung Neoplasms; Neoplasm Invasiveness; Phyllanthus; Transforming Growth Factor beta1 | 2015 |